Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 347NIH 33INDUSTRY 23OTHER_GOV 13NETWORK 7FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 6Deglutition Disorders 3Neoplasms 2Tinnitus 1Respiratory Aspiration 1Recurrence 1Ototoxicity 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Hearing Loss, Sensorineural 1Hearing Loss 1Esophageal Stenosis 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Squamous Cell 1Bites and Stings 1

Interventions

Celecoxib 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Mouth Neoplasms × Head & Neck × Clear all
NCT00953849 2017-03-07

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

VA Office of Research and Development

Phase 1/2 Completed
21 enrolled 10 charts
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡